{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:11:38Z","timestamp":1707523898618},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,19]]},"DOI":"10.7759\/cureus.3913","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T09:02:52Z","timestamp":1547888572000},"source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials"],"prefix":"10.7759","author":[{"given":"Sosipatros","family":"Bratsos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/16976-efficacy-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-neprilysin-inhibitors-in-the-treatment-of-chronic-heart-failure-a-review-of-landmark-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:13:36Z","timestamp":1707506016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/16976-efficacy-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-neprilysin-inhibitors-in-the-treatment-of-chronic-heart-failure-a-review-of-landmark-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7759\/cureus.3913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,19]]}}}